Reyvow Tablet
Product Images NDC 0002-4491

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Reyvow (NDC 0002-4491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reyvow 100mg 8ct 042 01

The text is a product description of a medication called REYVOW (lasmiditan) in tablet form, with each tablet containing 100mg of lasmiditan. It is a prescription-only medication, and the website REYVOW.com is mentioned for further details. However, the last line of text is not legible.*

FDA Label Image

Reyvow 50mg 8ct 040 01

REYVOW is a medication available only with a prescription that comes in the form of tablets containing 50 mg of lasmiditan. For more information, visit the website www.REYVOW.com. The product is manufactured by VANV. The text contains some errors.*

FDA Label Image

Figure 1 (Reyvow Uspi 1 V1)

This appears to be a graph showing the percentage of people achieving migraine pain freedom over time after taking different doses of a medication called REYVOW, as well as a placebo. The doses shown are 50mg, 100mg, and 200mg. The graph shows that a higher percentage of people achieved migraine pain freedom with REYVOW compared to the placebo, with the 200mg dose appearing to be the most effective. The time frame shown on the graph ranges from 0 to 2 hours after taking the medication.*

FDA Label Image

Figure 2 (Reyvow Uspi 2 V1)

The text appears to be a chart displaying the percentage of individuals achieving "MBS freedom" at various time points after taking different doses of a drug called "REYVOW" or a placebo. The drug is available in 50mg, 100mg, and 200mg doses. However, the meaning of "MBS freedom" and any additional information about the drug or study are not available.*

FDA Label Image

Structural Formula (Reyvow Uspi Chem V1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.